Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 14, 2014; 20(30): 10405-10418
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10405
Figure 2
Figure 2 ESAS and pancreatic cancer disease impact form in a patient with serum bilirubin 550 μmol/L, illustrating that only the disease specific instrument enables report on the patient’s most severe problem.